Skip to main content
Genus plc (GENSF)
OTCMKTS · Delayed Price · Currency is USD
22.43
+1.43 (6.81%)
Apr 23, 2025, 4:00 PM EDT

Genus Revenue

Genus had revenue of 336.40M GBP in the half year ending December 31, 2024, a decrease of -3.94%. This brings the company's revenue in the last twelve months to 671.60M, down -0.22% year-over-year. In the fiscal year ending June 30, 2024, Genus had annual revenue of 668.80M, down -3.03%.

Revenue (ttm)
671.60M GBP
Revenue Growth
-0.22%
P/S Ratio
1.67
Revenue / Employee
191.89K GBP
Employees
3,500
Market Cap
1.40B USD

Revenue Chart

* This company reports financials in GBP.

History

Fiscal Year End Revenue Change Growth
Jun 30, 2024668.80M-20.90M-3.03%
Jun 30, 2023689.70M96.30M16.23%
Jun 30, 2022593.40M19.10M3.33%
Jun 30, 2021574.30M22.90M4.15%
Jun 30, 2020551.40M62.90M12.88%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SS Innovations International 20.65M
Endo Inc. 1.76B
Veradigm 588.02M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
Glass House Brands 200.90M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Revenue Rankings

Genus News

More News